Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Terry Wepsic

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Immunopharmacology|December 3, 2022
Paraptosis and tumor immunityH Terry Wepsic, Neil Hoa
Cancer Biotherapy & Radiopharmaceuticals|November 6, 2007
Human allogeneic and murine xenogeneic dendritic cells are cytotoxic to human tumor cells via two distinct pathwaysPatric M Schiltz, Gregory J Lee, Jian Gang Zhang, et al.
Cytokine|August 11, 2007
Generation of human innate immune responses towards membrane macrophage colony stimulating factor (mM-CSF) expressing U251 glioma cells within immunodeficient (NIH-nu/beige/xid) miceChristina Delgado, Neil Hoa, Linda L Callahan, et al.
Cancer Gene Therapy|April 30, 2003
Human U251MG glioma cells expressing the membrane form of macrophage colony-stimulating factor (mM-CSF) are killed by human monocytes in vitro and are rejected within immunodeficient mice via paraptosis that is associated with increased expression of three different heat shock proteinsMartin R Jadus, Yijun Chen, Mehrdokht Tarbiyat Boldaji, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 24, 2007
Human monocytes kill M-CSF-expressing glioma cells by BK channel activationNeil T Hoa, Jian Gang Zhang, Christina L Delgado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeuticsJian Gang Zhang, Junichi Eguchi, Carol A Kruse, et al.
Blood|August 1, 2002
Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomasYijun Chen, Thomas Douglass, Edward W B Jeffes, et al.
International Immunopharmacology|August 9, 2008
Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologiesThomas G Douglass, Lara Driggers, Jian Gang Zhang, et al.
Biochemical and Biophysical Research Communications|April 13, 2005
Macrophage colony-stimulating factor expression in retrovirally transduced cells is dependent upon both the adherence status of the target cells and its 5' flanking untranslated regionJian-Gang Zhang, Qinghong Dan, Timothy C Fong, et al.
Cellular Immunology|July 27, 2002
T9 glioma cells expressing membrane-macrophage colony stimulating factor produce CD4+ T cell-associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic gliomasRamon Sanchez, Christopher Williams, Jose L Daza, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Immunopharmacology|December 3, 2022
Paraptosis and tumor immunityH Terry Wepsic, Neil Hoa
Cancer Biotherapy & Radiopharmaceuticals|November 6, 2007
Human allogeneic and murine xenogeneic dendritic cells are cytotoxic to human tumor cells via two distinct pathwaysPatric M Schiltz, Gregory J Lee, Jian Gang Zhang, et al.
Cytokine|August 11, 2007
Generation of human innate immune responses towards membrane macrophage colony stimulating factor (mM-CSF) expressing U251 glioma cells within immunodeficient (NIH-nu/beige/xid) miceChristina Delgado, Neil Hoa, Linda L Callahan, et al.
Cancer Gene Therapy|April 30, 2003
Human U251MG glioma cells expressing the membrane form of macrophage colony-stimulating factor (mM-CSF) are killed by human monocytes in vitro and are rejected within immunodeficient mice via paraptosis that is associated with increased expression of three different heat shock proteinsMartin R Jadus, Yijun Chen, Mehrdokht Tarbiyat Boldaji, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 24, 2007
Human monocytes kill M-CSF-expressing glioma cells by BK channel activationNeil T Hoa, Jian Gang Zhang, Christina L Delgado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeuticsJian Gang Zhang, Junichi Eguchi, Carol A Kruse, et al.
Blood|August 1, 2002
Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomasYijun Chen, Thomas Douglass, Edward W B Jeffes, et al.
International Immunopharmacology|August 9, 2008
Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologiesThomas G Douglass, Lara Driggers, Jian Gang Zhang, et al.
Biochemical and Biophysical Research Communications|April 13, 2005
Macrophage colony-stimulating factor expression in retrovirally transduced cells is dependent upon both the adherence status of the target cells and its 5' flanking untranslated regionJian-Gang Zhang, Qinghong Dan, Timothy C Fong, et al.
Cellular Immunology|July 27, 2002
T9 glioma cells expressing membrane-macrophage colony stimulating factor produce CD4+ T cell-associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic gliomasRamon Sanchez, Christopher Williams, Jose L Daza, et al.
Pageof 2